MSB 13.0% $1.31 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-842

  1. 340 Posts.
    lightbulb Created with Sketch. 60
    As much as I have enjoyed the scientific speculation of e.g. tfn 4003 as a marker of efficacy... do apologies but feel at this moment in time to say 'bollocks" to the many posters who, I think have a somewhat delusional inflated idea about their qualification to make scientific speculations in terms of this company. .Interested to see the next 6 months though
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.31
Change
0.150(13.0%)
Mkt cap ! $1.341B
Open High Low Value Volume
$1.15 $1.33 $1.15 $19.07M 15.28M

Buyers (Bids)

No. Vol. Price($)
10 72556 $1.30
 

Sellers (Offers)

Price($) Vol. No.
$1.31 10202 3
View Market Depth
Last trade - 15.30pm 23/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.